http://www.unboundmedicine.com/medline/ebm/research/clopidogrelUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19893641/full_citation/Late_thrombosis_of_sirolimus_eluting_stent:_a_multifactorial_problem_Kranjec I, Cerne A 
Late thrombosis of sirolimus-eluting stent: a multifactorial problem. [Journal Article]
Case Report Med 2009.:816715.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19892299/full_citation/New_antiplatelet_agents:_why_they_are_needed_Franchini M, Mannucci PM 
New antiplatelet agents: why they are needed. [Journal Article]
Eur J Intern Med 2009 Dec; 20(8):733-8.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19892050/full_citation/Effectiveness_of_two_year_clopidogrel_+_aspirin_in_abolishing_the_risk_of_very_late_thrombosis_after_drug_eluting_stent_implantation__from_the_TYCOON_[two_year_ClOpidOgrel_need]_study__Tanzilli G, Greco C, Pelliccia F, et al. 
Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). [Journal Article]
Am J Cardiol 2009 Nov 15; 104(10):1357-61.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891556/full_citation/Clopidogrel_pharmacogenomics_and_risk_of_inadequate_platelet_inhibition:_US_FDA_recommendations_Ellis KJ, Stouffer GA, McLeod HL, et al. 
Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations. [Journal Article]
Pharmacogenomics 2009 Nov; 10(11):1799-817.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19891080/full_citation/HOTLINE_I_PLATO_favours_ticagrelor_over_clopidogrel_in_ACS_HOTLINE I, PLATO favours ticagrelor over clopidogrel in ACS. [Journal Article]
Eur Heart J 2009 Nov; 30(21):2541.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19888916/full_citation/Clopidogrel_application:_beyond_coronary_artery_disease_Zeng C 
Clopidogrel application: beyond coronary artery disease. [JOURNAL ARTICLE]
Clin Sci (Lond) 2009 Nov 4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19886132/full_citation/Perioperative_clopidogrel_is_seven_days_enoughGrujic D, Martin D 
Perioperative clopidogrel is seven days enough? [Journal Article]
Am Surg 2009 Oct; 75(10):909-13.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19884296/full_citation/Dual_antiplatelet_therapy_in_coronary_artery_disease:_A_case_based_approach_Raymond C, Menon V 
Dual antiplatelet therapy in coronary artery disease: A case-based approach. [JOURNAL ARTICLE]
Cleve Clin J Med 2009 Nov; 76(11):663-670.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19882081/full_citation/P2Y12_inhibitors_Collet JP, Montalescot G 
P2Y12 inhibitors. [Journal Article]
Hamostaseologie 2009 Sep; 29(4):339-48.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19882080/full_citation/Platelet_monitoring_for_PCI_Tantry US, Gurbel PA 
Platelet monitoring for PCI. [Journal Article]
Hamostaseologie 2009 Sep; 29(4):368-75.
Abstract | Full Citation